Trial Profile
A prospective, randomized, multi-center double-blind study of early corticosteroid cessation vs. long term corticosteroid therapy with Prograf [tacrolimus] and CellCept [mycophenolate mofetil] in primary renal transplant patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Mar 2013
Price :
$35
*
At a glance
- Drugs Methylprednisolone (Primary) ; Mycophenolate mofetil (Primary) ; Prednisone (Primary) ; Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Pharmacokinetics; Therapeutic Use
- Sponsors Astellas Pharma
- 16 Apr 2008 New trial record.